Interestingly, serum ficolin-2 concentrations were higher in chronic HBV patients than in healthy controls and HBV carriers and decreased with positive treatment response, but was lowest in individuals with hepatocellular carcinoma and cirrhosis (60). The gene discussed is FCN2; the disease is Cirrhosis.